What is Rachel Shell's NPI number?

Rachel Shell's National Provider Identifier (NPI) is 1942339932, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Rachel Shell's specialty?

Rachel Shell is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).

Where is Rachel Shell located?

Rachel Shell's practice location on file with NPPES is 100 Fitness Dr, Bourbonnais, IL 60914-9584.

What is Rachel Shell's phone number?

The practice phone number listed in the NPPES registry for Rachel Shell is (815) 936-8909.

Does Rachel Shell accept Medicare?

Rachel Shell is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Rachel Shell's NPI active?

Yes — Rachel Shell's NPI (1942339932) is active in the NPPES registry as of the last update on 2024-05-15.

IndividualActiveAccepts Medicare

Rachel Shell, MD

NPI 1942339932 · Endocrinology, Diabetes & Metabolism Physician · Bourbonnais, IL

Rachel Shell, MD is a Endocrinology, Diabetes & Metabolism Physician provider in Bourbonnais, IL (NPI 1942339932).

Provider details

NPI number: 1942339932
Entity type: Individual
Primary specialty: Endocrinology, Diabetes & Metabolism PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 036128549 (IL)

Practice location

100 Fitness Dr

Bourbonnais, IL 60914-9584

Phone: (815) 936-8909

Street-level locationGet directions

More IL providers

Mailing address

100 Fitness Dr

Bourbonnais, IL 60914-9584

Specialties & taxonomies

Endocrinology, Diabetes & Metabolism PhysicianPrimary207RE0101XLicense 036128549 (IL)
Allopathic & Osteopathic Physicians
Internal Medicine Physician207R00000XLicense 133937 (NC)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Endocrinology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(91/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure33% of score
19 yrs in NPPES registry
Profile completeness33% of score
100% of core fields populated
Practice footprint20% of score
1 documented practice location
Open Payments transparency13% of score
Has Open Payments disclosures (2024)

Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	953	$94
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	397	$16
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	276	$33
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	11	$129
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	11	$64

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 61 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	996	200
Semaglutidebrand: Ozempic	290	69
Metformin Hclbrand: Metformin Hcl Er	251	62
Glipizidebrand: Glipizide Er	190	47
Levothyroxine Sodiumbrand: Synthroid	173	38
Dulaglutidebrand: Trulicity	173

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$234 across 10 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-03-05
Last updated: 2024-05-15
Certified: 2024-05-15

Frequently asked questions

What is Rachel Shell's NPI number?: Rachel Shell's National Provider Identifier (NPI) is 1942339932, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Rachel Shell's specialty?: Rachel Shell is listed in the NPPES registry with a primary specialty of Endocrinology, Diabetes & Metabolism Physician (Allopathic & Osteopathic Physicians).
Where is Rachel Shell located?: Rachel Shell's practice location on file with NPPES is 100 Fitness Dr, Bourbonnais, IL 60914-9584.
What is Rachel Shell's phone number?: The practice phone number listed in the NPPES registry for Rachel Shell is (815) 936-8909.
Does Rachel Shell accept Medicare?: Rachel Shell is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Rachel Shell's NPI active?: Yes — Rachel Shell's NPI (1942339932) is active in the NPPES registry as of the last update on 2024-05-15.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	953	$94
Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211	397	$16
Continuous Monitoring of Blood Sugar Level in Tissue Fluid Using Sensor Under Skin With Interpretation and Report95251	276	$33
New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204	11	$129
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	11	$64

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 61 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Levothyroxine Sodium	996	200
Semaglutidebrand: Ozempic	290	69
Metformin Hclbrand: Metformin Hcl Er	251	62
Glipizidebrand: Glipizide Er	190	47
Levothyroxine Sodiumbrand: Synthroid	173	38
Dulaglutidebrand: Trulicity	173

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$234 across 10 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments